Trials / Completed
CompletedNCT01211028
Adipose CELL Derived Regenerative Endothelial Angiogenic Medicine
Safety of Autologous Adipose Derived Stroma/Stem Cells to Treat Critical Leg Ischemia.
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- University Hospital, Toulouse · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to evaluate the safety and feasibility of regenerative therapy with expanded adipose derived stroma/stem cells sue, administered intramuscularly in patients with critical leg ischemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Expanded autologous ASCs | Drug: Expanded autologous adipose-derived adult stroma/stem cells |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2010-09-29
- Last updated
- 2017-05-11
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01211028. Inclusion in this directory is not an endorsement.